The Joint Committee on Vaccination and Immunisation (JCVI) is an expert scientific advisory committee that advises the UK government on matters relating to vaccination and immunisation.

The JCVI has reviewed evidence from manufacturers on the efficacy, safety and duration of protection of RSV immunisation products alongside clinical and epidemiological data on the burden of RSV in neonates and infants, and older adults.

JCVI statement

On 7 June 2023, the JCVI issued a statement advising that an RSV immunisation programme should be developed to protect neonates and infants, and older adults, in response to the significant burden of RSV illness in the UK population, which has a considerable impact on NHS services during the winter months.

Read the full JCVI statement.

Updated Green Book

Read the updated RSV chapter in the Green Book.